Buscar resultados de ensayos clínicos
Chordoma - 25 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Nilotinib With Radiation for High Risk Chordoma Condición: Chordoma Fecha: 2011-07-28 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma Condición: Chordoma Fecha: 2010-07-28 Intervenciones: Drug: Imatinib + LBH589 Escalating doses of imatinib and LBH589 will be administered. |
Completed |
Nombre del estudio: Efficacy and Safety of Imatinib in Chordoma Condición: Chordoma Fecha: 2005-09-07 Intervenciones: Drug: imatinib |
Active, not recruiting |
Nombre del estudio: Proton Beam Therapy for Chordoma Patients Condición: Chordoma Fecha: 2007-07-02 Intervenciones:
|
Completed |
Nombre del estudio: Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families Condición: Chordoma Fecha: 2006-06-19 |
Completed |
Nombre del estudio: Chordoma Family Study Condición: Chordoma Fecha: 2006-12-12 |
Recruiting |
Nombre del estudio: Ion Irradiation of Sacrococcygeal Chordoma Condición: Sacral Chordoma Fecha: 2013-03-09 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma Condición: Chordoma Fecha: 2017-03-31 Intervenciones: Drug: Palbociclib application on 21 consecutive days of a 28 days cycle |
Recruiting |
Nombre del estudio: Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease Condición: Chordoma Fecha: 2016-12-02 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Afatinib in Locally Advanced and Metastatic Chordoma Condición: Chordoma Fecha: 2017-02-10 Intervenciones: Drug: Afatinib Afatinib will be given daily in a dose of 40 mg orally in a 4 week cycle until disease pr |